Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Clinsy Pazhepurackel"'
Autor:
Marian S Wettstein, Jasjit K Rooprai, Clinsy Pazhepurackel, Christopher J D Wallis, Zachary Klaassen, Elizabeth M Uleryk, Thomas Hermanns, Neil E Fleshner, Alexandre R Zlotta, Girish S Kulkarni
Publikováno v:
PLoS ONE, Vol 14, Iss 4, p e0216255 (2019)
ObjectivesTo systematically review and meta-analyze the current literature in a methodologically rigorous and transparent manner for quantitative evidence on survival outcomes among patients diagnosed with muscle-invasive bladder cancer that were tre
Externí odkaz:
https://doaj.org/article/6fa4e8b41f924527a3ab333d9e88c5e0
Autor:
Robert J. Hamilton, Alexandre R. Zlotta, Daniel Eberli, Jaime O. Herrera-Caceres, Christian D. Fankhauser, Clinsy Pazhepurackel, Cédric Poyet, Girish S. Kulkarni, Michael Nesbitt, Marian S. Wettstein, Ardalan E. Ahmad, Luke A. David, Neil Fleshner, Aatif A. Qureshi, Antonio Finelli, Karim Saba, Alex Zisman, Tullio Sulser, Thomas Hermanns
Publikováno v:
The Prostate. 81:286-294
BACKGROUND The therapeutic role of extended (ePLND) versus nonextended pelvic lymph node dissection (nePLND) to remove occult micrometastases in men undergoing radical prostatectomy for localized prostate cancer (PC) is conflicting. Therefore, our ai
Autor:
Girish S. Kulkarni, Marian S. Wettstein, Tullio Sulser, Cédric Poyet, Aline S Neumann, Thomas Hermanns, Clinsy Pazhepurackel, Jaime O. Herrera-Caceres, Dixon T.S. Woon
Publikováno v:
Journal of Urology. 201
INTRODUCTION AND OBJECTIVES:Photoselective vaporization of the prostate (PVP) with the so-called 532nm greenlight laser is an accepted treatment modality for non-neurogenic lower urinary tract symp...
Autor:
Clinsy Pazhepurackel, Alexandre R. Zlotta, Marian S. Wettstein, Jasjit K. Rooprai, Zachary Klaassen, Elizabeth Uleryk, Thomas Hermanns, Girish S. Kulkarni, Neil E. Fleshner, Christopher J.D. Wallis
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 4, p e0216255 (2019)
PLoS ONE, Vol 14, Iss 4, p e0216255 (2019)
ObjectivesTo systematically review and meta-analyze the current literature in a methodologically rigorous and transparent manner for quantitative evidence on survival outcomes among patients diagnosed with muscle-invasive bladder cancer that were tre